Publication:
Natural products, PGC-1 alpha, and Duchenne muscular dystrophy

dc.contributor.authorSuntar, Ipek
dc.contributor.authorSoldevila Verdeguer, Carla
dc.contributor.authorBelwal, Tarun
dc.contributor.authorSilva, Ana Sanches
dc.contributor.authorVacca, Rosa Anna
dc.contributor.authorTewari, Devesh
dc.contributor.authorSobarzo-Sanchez, Eduardo
dc.contributor.authorNabavi, Seyed Fazel
dc.contributor.authorShirooie, Samira
dc.contributor.authorDehpour, Ahmad Reza
dc.contributor.authorXu, Suowen
dc.contributor.authorYousefi, Bahman
dc.contributor.authorMajidinia, Maryam
dc.contributor.authorDaglia, Maria
dc.contributor.authorD'Antona, Giuseppe
dc.contributor.authorNabavi, Seyed Mohammad
dc.date.accessioned2024-09-13T09:13:32Z
dc.date.available2024-09-13T09:13:32Z
dc.date.issued2020-05
dc.description.abstractPeroxisome proliferator-activated receptor gamma (PPAR gamma) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPAR gamma coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1 alpha are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1 alpha is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPAR gamma activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1 alpha.en
dc.description.sponsorshipThis work was supported by the crowd funding #Sport4Therapy to Giuseppe D'Antona (Italy). A. Sureda was supported by Instituto de Salud Carlos III, Grant Number: CIBEROBN CB12/03/30038.es_ES
dc.format.number5es_ES
dc.format.page734-745es_ES
dc.format.volume10es_ES
dc.identifier.citationSuntar I, Sureda Gomila A, Belwal T, Sanches Silva A, Vacca RA, Tewari D, et al. Natural products, PGC-1 alpha, and Duchenne muscular dystrophy. Acta Pharm Sin B. 2020 May;10(5):734-45. Epub 2020 Jan 8.en
dc.identifier.doi10.1016/j.apsb.2020.01.001
dc.identifier.e-issn2211-3843es_ES
dc.identifier.issn2211-3835
dc.identifier.journalActa Pharmaceutica Sinica Bes_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/17243
dc.identifier.pubmedID32528825es_ES
dc.identifier.puiL2004992484
dc.identifier.scopus2-s2.0-85079816616
dc.identifier.urihttps://hdl.handle.net/20.500.12105/22926
dc.identifier.wos538982700002
dc.language.isoengen
dc.publisherInst Materia Medica, Chinese Acad Medical Sciencesen
dc.relation.publisherversionhttps://dx.doi.org/10.1016/j.apsb.2020.01.001en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMuscular dystrophy
dc.subjectNatural product
dc.subjectPeroxisome proliferatoractivated receptor gamma coactivator 1 alpha;
dc.subjectPPAR gamma activation
dc.subjectReactive oxygen species
dc.subjectMitochondrial oxidative phosphorylation
dc.titleNatural products, PGC-1 alpha, and Duchenne muscular dystrophyen
dc.typereview articleen
dspace.entity.typePublication

Files